How should thyroid‑stimulating hormone (TSH) levels be evaluated and managed in the pre‑operative assessment to determine peri‑operative fitness for surgery?

Preoperative TSH Evaluation and Management for Surgical Fitness

Patients with hyperthyroidism undergoing thyroid surgery should ideally be rendered euthyroid with methimazole preoperatively, but recent evidence demonstrates that surgery can be safely performed in the hyperthyroid state when cardiovascular stability is achieved, making biochemical euthyroidism a preference rather than an absolute requirement.

For Hyperthyroid Patients Requiring Thyroid Surgery

Standard Preoperative Preparation (Preferred Approach)

For Graves' Disease patients:

• Render euthyroid with methimazole before thyroidectomy 1
• Add potassium iodide in the immediate preoperative period (5-7 drops Lugol's solution or 1-2 drops SSKI three times daily for 10 days before surgery) 1
• This approach prevents thyroid storm, which can be precipitated by surgical stress, anesthesia, or thyroid manipulation 1

For toxic multinodular goiter (TMNG) or toxic adenoma (TA):

• Achieve euthyroid state with methimazole pretreatment (unless allergic) 1
• Use beta-adrenergic blockade with or without methimazole 1
• Do not use preoperative iodine in this setting (unlike Graves' disease) 1

Alternative Approach When Euthyroidism Cannot Be Achieved

In exceptional circumstances when euthyroidism is not possible (allergy to antithyroid drugs, urgent surgery need, treatment-resistant disease, or patient non-compliance):

• Adequately treat with beta-blockade plus potassium iodide in the immediate preoperative period 1
• Ensure the surgeon and anesthesiologist have experience managing hyperthyroid patients 1
• Focus on achieving cardiovascular stability rather than biochemical euthyroidism 2

Recent high-quality evidence supports this approach: A 2025 meta-analysis of 1,336 patients found no significant differences in postoperative complications between preoperatively euthyroid and hyperthyroid patients, including temporary hypocalcemia (OR: 0.50), permanent hypocalcemia (OR: 0.46), hoarseness, bleeding risks, or operative time 3. Only one case of thyroid storm occurred in the hyperthyroid group with no mortalities 3.

Critical Caveat About Patient Selection

The safety of operating on hyperthyroid patients depends heavily on:

• Cardiovascular stability - this is the key determinant, not TSH levels 2
• High-risk patients (elderly, cardiovascular disease, severe hyperthyroidism) should receive beta-blockade and potentially methimazole pretreatment even if definitive surgery is planned 1
• Experienced surgical and anesthesia teams are essential 1

For Hypothyroid Patients Requiring Non-Thyroid Surgery

Preoperative Assessment

Treatment of recognized hypothyroidism is recommended before any surgical procedure whenever possible:

• Document euthyroidism by measuring serum TSH as part of preoperative evaluation 4
• This strategy results in better surgical outcomes with improved morbidity and mortality 4

Risks of Operating on Untreated Hypothyroid Patients

Hypothyroid patients face increased perioperative complications 5:

• Intraoperative hypotension during noncardiac surgery (61% vs 30% in controls, p<0.05)
• Heart failure during cardiac surgery (29% vs 6%, p<0.05)
• Gastrointestinal complications postoperatively (19% vs 1%, p<0.02)
• Neuropsychiatric complications (38% vs 18%, p<0.02)
• Blunted fever response to infection (35% vs 79% manifested fever, p<0.001)

Important Exception - Coronary Artery Disease

Do not treat hypothyroidism first if the patient has angina or requires coronary revascularization:

• Preoperative thyroid hormone therapy could tax the ischemic myocardium 4
• Address coronary blood flow first (bypass grafting, angioplasty, or stenting)
• Initiate thyroid hormone therapy afterwards 4

Critical Distinction: Euthyroid Sick Syndrome

Avoid misinterpreting low thyroid hormones in acutely ill surgical patients:

• Distinguish between true hypothyroidism and "euthyroid sick syndrome" 4
• No clear evidence supports thyroid hormone replacement in euthyroid sick syndrome, and it may be potentially harmful 4
• Do not treat with T3 in surgical patients with nonthyroidal illness until therapeutic efficacy is demonstrated 4

Postoperative TSH Monitoring

For patients undergoing total laryngectomy or thyroid surgery:

• 41.4% of patients had TSH testing within 90 days postoperatively, but mean interval was 222 days 6
• 58.6% developed hypothyroidism after surgery 6
• Monitor thyroid function closely in the perioperative period, especially after partial or total thyroid removal (OR = 2.631 for elevated postoperative TSH) 6

Practical Algorithm

1. Identify thyroid status preoperatively - measure TSH, free T4, and T3 if hyperthyroidism suspected
2. For hyperthyroid patients needing thyroid surgery:
   • First choice: Render euthyroid with methimazole + add potassium iodide preoperatively
   • If impossible: Beta-blockade + potassium iodide with experienced team
3. For hypothyroid patients needing non-thyroid surgery:
   • Treat hypothyroidism first and document euthyroid TSH
   • Exception: Defer treatment if coronary revascularization needed first
4. Ensure cardiovascular stability regardless of biochemical thyroid status
5. Refer to high-volume thyroid surgeon (>30 cases/year, ideally >100/year) 1